Published in
Elsevier, The Lancet Oncology, 10(20), p. 1386-1394, 2019
DOI: 10.1016/s1470-2045(19)30513-3
Links
Tools
Individualised axitinib regimen for patients with metastatic renal cell carcinoma after treatment with checkpoint inhibitors: a multicentre, single-arm, phase 2 study
Journal article published in 2019 by
Moshe C. Ornstein,
Sumanta K. Pal,
Laura S. Wood,
Jackie M. Tomer,
Brian P. Hobbs,
Xuefei S. Jia,
Kimberly D. Allman,
Allison Martin,
Thomas Olencki,
Nancy B. Davis 
,
Timothy D. Gilligan,
Amir Mortazavi,
W. Kimryn Rathmell,
Jorge A. Garcia,
Brian I. Rini
,
Timothy D. Gilligan,
Amir Mortazavi,
W. Kimryn Rathmell,
Jorge A. Garcia,
Brian I. Rini
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 